BRCA1 and ovarian cancer: In summary, the 3'UTR polymorphism in PHB appears not to be associated with ovarian cancer risk in women carrying of one of the three Polish BRCA1 founder mutations even when accounting for environmental influences that are considered important in disease risk determination.